Benzinga | Aug 4, 2021 05:38PM EDT

Abiomed Q1 Adj. EPS $1.10 Beats $1.05 Estimate, Sales $252.60M Beat $240.91M Estimate

Abiomed (NASDAQ:ABMD) reported quarterly earnings of $1.10 per share which beat the analyst consensus estimate of $1.05 by 4.76 percent. This is a 89.66 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $252.60 million which beat the analyst consensus estimate of $240.91 million by 4.85 percent. This is a 53.23 percent increase over sales of $164.85 million the same period last year.